患者认知影响膀胱过度活动症三线治疗推进
本研究通过混合方法(访谈+问卷)调查已尝试行为调整和药物治疗的OAB患者选择三线治疗的原因。69例患者中51例完成访谈和问卷,平均年龄71岁(SD=10.4),75%打算接受三线治疗。主要主题包括追求更好生活质量、因漏尿感到尴尬及药物问题;阻碍因素包括对侵入性和副作用的担忧及就医限制。经济负担与患者对三线治疗(包括onabotulinumtoxinA和经皮胫神经刺激)的兴趣和决策相关。
要点
- 多数OAB患者因尴尬和追求生活质量愿意推进三线治疗。
- 对治疗侵入性和副作用的担忧是阻碍三线治疗的主要因素。
- OAB治疗的经济负担与患者对三线治疗的兴趣和决策相关。
核心结论
- 大多数患者希望推进三线OAB治疗,动机包括尴尬,但担心治疗副作用。
- OAB治疗的经济负担与患者对三线治疗(包括onabotulinumtoxinA和经皮胫神经刺激)的兴趣和决策相关。
研究设计与样本
- 混合方法研究,包括患者访谈和问卷调查,2018年10月至2019年8月入组。
- 纳入标准:症状诊断、已尝试行为调整和OAB药物治疗的患者。
- 共69例患者同意,4例退出,51例完成访谈和问卷数据。
主要发现
- 55%患者为白人,45%为非裔美国人,平均年龄71岁(SD=10.4)。
- 75%打算接受三线OAB治疗,31例(61%)对特定三线治疗表示兴趣。
- 访谈主要主题:渴望更好生活质量、因意外漏尿感到尴尬、药物问题。
- 阻碍三线治疗的主题:担心侵入性和副作用、就医限制。
临床怎么用
- 临床中应关注患者对生活质量和尴尬的诉求,同时充分沟通三线治疗的侵入性和副作用。
- 评估OAB治疗经济负担可能影响患者对三线治疗的选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to understand the reasons patients choose to pursue third-line overactive bladder (OAB) therapy. MATERIALS AND METHODS: We conducted a mixed methods study that included patient interviews and survey data. Eligible patients were diagnosed by symptoms, had tried behavioral modifications, and OAB medications enrolled from October 2018 to August 2019. In addition to interviews, patients completed 4 surveys: the Pelvic Floor Distress Inventory, Overactive Bladder Questionnaire Short Form, Life Orientation Test-Revised, and a patient confidence in the health care system survey. Qualitative interview data were analyzed thematically. Logistic regression and chi-square analysis was used to analyze survey data. RESULTS: A total of 69 patients were consented, 4 withdrew, and 51 completed both interview and survey data. Overall 55% of patients were Caucasian, 45% were African American, and their average age was 71 (SD=10.4); 75% intended to pursue third-line OAB therapy and 31 (61%) expressed interest in a specific third-line therapy. Major interview themes included a desire for a better quality of life, embarrassment with accidents, and problems with medication. Themes leading patients away from third-line OAB treatment included concern about invasiveness and side effects of treatments, and restrictions to accessing care. CONCLUSIONS: Most patients desired to progress to third-line OAB therapy, were motivated by embarrassment, but were concerned about treatment side effects. We found that economic burden of OAB treatment is associated with patient interest in and decision to receive third-line therapies to include onabotulinumtoxinA and percutaneous tibial nerve stimulation. Improved quality of life, medication frustration, and concerns about side effects of further therapy are themes patients identified when patients considered third-line overactive bladder therapy.
引用
- Iyer S, Amegashie C, deMartelly V, et al. Patient Perceptions Impact Progression to Third-Line Therapy for Treatment of Overactive Bladder. J Urol. 2021. PMID: 34184922. doi:10.1097/JU.0000000000001950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。